Revenue: As of FY2026 Q2, the actual value is USD 0.

EPS: As of FY2026 Q2, the actual value is USD -0.29.

EBIT: As of FY2026 Q2, the actual value is USD -1.036 M.

The provided reference, a Form 8-K filing by Pulmatrix, Inc., announces the issuance of a press release regarding its financial results for the second fiscal quarter ended June 30, 2026, and a corporate update. However, the actual financial results and corporate update are contained in the press release (Exhibit 99.1), which is not part of the provided text. Consequently, specific financial metrics, operational metrics, or outlook/guidance cannot be extracted from this reference.